Cards (5)

    • comparison of penem and carbapenem
      • carbon has about half the diameter as that of sulfur
      • carbopenem ring thus is more strained than the penem ring
      • the fused beta lactam ring is thus more reactive and potent against PBPs
      • carbopenem is also less stable and easier to be hydrolyzed, thus prohibiting oral bioavailability
    • thienamycin
      • not a real drug but the lead compound of carbapenem antibiotics
      • attractive properties:
      • extremely potent in vitro
      • broad-spectrum antimicrobial activity in vitro
      • very stable and even inhibitor to beta-lactamase d/t the alpha-oriented hydroxyethyl group
      • penetrates through porin (small zwitter ion)
      • shortcomings:
      • very unstable at acidic or alkaline pHs
      • concentration-dependent self-inactivation of beta-lactam ring in solution by the primary amine
      • hydrolysis by renal dehydropeptidase-I
      • half-life too short to be useful in vivo
    • imipenem + silastatin (primaxin): a "precious", "reserved" antibiotics
      • improvements from thienamycin:
      • the primary amine group is replaced w/ a non-nucleophilic imine group
      • long enough plasma half-life (~ 1h) d/t the inhibition of renal dehydropeptidase-I by cilastatin
      • activities and clinical applications:
      • broader spectrum than any available antibiotics in US
      • orally inactive
      • induces the expression of beta-lactamase
      • seldom the first line drug but a reserved parenteral drug for special cases of serious infection
    • second-generation carbapenems
      • meropenem (merrem)
      • used for about 10 yrs to treat CNS infections
      • also approved for complicated skin infections
      • stable to and even inhibitor to most beta-lactamases
      • small zwitter ions and penetrates through porins well
      • intrinsically stable to renal dehydropeptidase-I and is used alone
      • potent and broad-spectrum
      • "precious" antibiotic drugs usually reserved for serious hospital acquired infections that are resistant to other beta-lactams
    • ertapenem (invanz)
      • one additional negative charge compared w/ other carbapenems
      • a longer serum half-life that allows once-daily dosing
      • inferior activity against gram negative P. aeruginosa and Acinetobacter spp.
      • its spectrum of activity against gram positive organisms, Enterobacteriaceae, and anaerobes makes it attractive for use in intra-abdominal and pelvic infections